Sargent Bickham Lagudis LLC Exact Sciences Corp Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 235 shares of EXAS stock, worth $14,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235
Previous 235
-0.0%
Holding current value
$14,186
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
674Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.07 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$956 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$865 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$728 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$403 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...